Verona Pharma is delisting and cancelling its Ordinary shares from trading on AIM. It is consolidating trading on the NASDAQ market where it will retain its listing of American Depositary Shares (ADSs) under the ticker symbol VRNA. No general meeting is required to complete the AIM Delisting, which is expected to occur market close 29 October 2020. Each ADS represents eight Ordinary shares and are denominated in $. As per the company’s website, there are three options available now for
21 Sep 2020
AIM delisting; three options available for shareholders
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
AIM delisting; three options available for shareholders
Verona Pharma plc Sponsored ADR (VRNA:NAS) | 0 0 0.0%
- Published:
21 Sep 2020 -
Author:
Edward Thomason -
Pages:
4
Verona Pharma is delisting and cancelling its Ordinary shares from trading on AIM. It is consolidating trading on the NASDAQ market where it will retain its listing of American Depositary Shares (ADSs) under the ticker symbol VRNA. No general meeting is required to complete the AIM Delisting, which is expected to occur market close 29 October 2020. Each ADS represents eight Ordinary shares and are denominated in $. As per the company’s website, there are three options available now for